Benzinga's Daily Brief On Trending Tickers For April 18, 2022: Casa Systems, Twitter, DiDi Global, And More

Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.

The data on the trending tickers is compiled from a list of most-discussed tickers on Benzinga Pro, and the popular Reddit forum WallStreetBets.

Casa Systems Inc CASA The company was awarded a multi-year contract to provide 5G core network functions; to that end, shares are trading 49.6% higher to $5.82 during Monday’s pre-market session.

Bank of America Corp BAC The company reported earnings per share of $0.80, beating analyst estimates of $0.74 – while also reporting quarterly sales of $23.2 billion, beating the analyst consensus estimate of $23.11 Billion.

Natus Medical Inc NTUS The company announced it would be acquired by investment firm ArchiMed in a deal valued around $1.2 billion, shareholders will receive $33.50 for each share, representing a 29% premium to current share prices. NTUS is up 28.3% at $33.42 in pre-market session.

Twitter Inc TWTR Reuters reported on Friday that private equity firm Thoma Bravo is interested in acquiring Twitter, creating competition with Tesla Inc TSLA chief Elon Musk.

Also Read: Tesla Stock Split And More: What Retail Investors Want To Know From Elon Musk And Team On Wednesday's Quarterly Call

Nektar Therapeutics NKTR The company ended a global clinical trial for a cancer-killing drug alongside Bristol Myers-Squibb BMY, causing shares to plummet 28.73% during Monday’s pre-market session.

DiDi Global Inc - ADR DIDI Shares are trading 19.1% lower during Monday’s pre-market session as the company announced it would hold a shareholder meeting in May to vote on a voluntary delisting from the New York Stock Exchange.

Safe T Group American Depositary Share SFET shares are trading 13.24% higher during Monday’s pre-market session as the company reported first-quarter sales guidance above analyst estimates.